5Gerard SL, Unique unbalanced X; X translocation (Xq22 : p11.2) in a woman with primary amenorrhea but without Ullrich-Turner syndrome[J]. Am J Med Genet, 1995,9(3) :414-416.
3Yvonne KP, Sabine M, Theo S, et al. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metab- olism and risk factors for cardiovascular disease in girls with turner syndrome [J]. J Clin Endocrinol Metab, 2002,87 (12) : 5442-5448.
4Bramnert M, Segerlantz M, Laurila E, et al. Growth hormone re- placement therapy induces insulin resistance by activating the glucose-fatty acid cycle [J]. J Clin Endocrinol Metab, 2003, 88: 1455-1463.
5Ihara K, Inuo M, Kuromaru R. The Leu544Ile polymorphism of the growth hormone receptor gene affects the serum cholesterol levels during GH treatment in children with GH deficiency[J]. Clin Endocrinol (Oxf), 2007,67 (2) : 212-217.
6Hilczer M, Smyczynska J, Stawerska R, et al. Effects of one-year low-dose growth hormone (GH) therapy on body composition, lipid profile and carbohydrate metabolism in young adults with childhood-onset severe GH deficiency con- finned after completion of growth promotion [J]. Endokrynol Pol, 2008,59 (4) : 292-300.
7Laura M, Rosalba B, Laura C, et al. Turner syndrome, insulin sensitivity and growth hormone treatment[J]. Horm Res, 2005, 64 (S3) :51-57.
8Choi IK, Kim DH, Kim HS. The abnormalities of carbohydrate metabolism in Turner syndrome : analysis of risk factors associ- ated with impaired glucose tolerance [J]. Eur J Pedialr, 2005, 164(4) :442-447.
9Gravholt CH, Juul S, Naeraa RW, et al. Morbidity in Turner syn- drome[J]. J Clin Epidemiol, 1998,51(2) : 147-158.
10Gopal AS, Arora NS, Vardanian S, et al. Utility of transesoph- aged echocardiography for the characterization of cardiovascular anomalied associated with Turner syndrome [J ]. J Am Soc Echo- cardiogr, 2001,14 ( 1 ) : 60-62.
